Amarin reported $287.36M in Current Liabilities for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
DBV Technologies DBVT:US USD 28.39M 2.04M
Alnylam Pharmaceuticals ALNY:US USD 772.79M 115.11M
Amarin AMRN:US USD 287.36M 74.22M
AstraZeneca AZN:LN USD 24.85B 3.04B
Esperion Therapeutics ESPR:US USD 82.34M 70K
GlaxoSmithKline GSK:LN GBP 20.95B 16.88B
Halozyme Therapeutics HALO:US USD 109.38M 90.13M
Heron Therapeutics HRTX:US USD 93.88M 15.62M
Intercept Pharmaceuticals ICPT:US USD 221.58M 70.16M
IONIS PHARMACEUT IONS:US USD 283.45M 15.64M
JAZZ PHA JAZZ:US USD 812.95M 107.51M
Nektar Therapeutics NKTR:US USD 83.99M 21M
Neurocrine Biosciences NBIX:US USD 485.1M 199.4M
Novartis NOVN:VX USD 28.16B 514M
Teva Pharmaceutical Industries TEVA:US USD 11.53B 538M